BetaEntity Annotation Prototype
← Back to drugs

Annotated abstract

Diagnosis and management of resistant hypertension

bmj · 2026-06-02 · canonical JSON source

2 visible annotations · policy: published · automated confidence ≥ 75.00%

Document resource

In this article by Schiffrin and colleagues (BMJ 2024;385:e079108, doi:10.1136/bmj-2023-079108, published 19 June 2024), the doses of loundrostat tested have been corrected to 12.5 mg and 25 mg twice daily. The article and PDF have been updated.